Michael Gejl

1.5k total citations · 1 hit paper
25 papers, 1.2k citations indexed

About

Michael Gejl is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, Michael Gejl has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Physiology and 6 papers in Surgery. Recurrent topics in Michael Gejl's work include Diabetes Treatment and Management (13 papers), Diet and metabolism studies (8 papers) and Diabetes Management and Research (7 papers). Michael Gejl is often cited by papers focused on Diabetes Treatment and Management (13 papers), Diet and metabolism studies (8 papers) and Diabetes Management and Research (7 papers). Michael Gejl collaborates with scholars based in Denmark, Canada and United States. Michael Gejl's co-authors include Birgitte Brock, Jørgen Rungby, Albert Gjedde, Lærke Egefjord, Kim Vang, Niels Møller, Arne Møller, Hans Brændgaard, Hanne Gottrup and Anders Rodell and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Michael Gejl

25 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

2016 346 citations Michael Gejl, Albert Gjedde et al. Frontiers in Aging Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Gejl Denmark	16	563	457	275	203	181	25	1.2k
Kim Vang Denmark	16	339 0.6×	408 0.9×	213 0.8×	150 0.7×	283 1.6×	22	1.2k
Lærke Egefjord Denmark	10	370 0.7×	331 0.7×	191 0.7×	166 0.8×	135 0.7×	10	834
A Pernet United Kingdom	17	593 1.1×	339 0.7×	222 0.8×	329 1.6×	116 0.6×	33	1.2k
Mei Qiu China	15	230 0.4×	227 0.5×	246 0.9×	152 0.7×	153 0.8×	63	935
Juan Antonio García-Arnés Spain	23	378 0.7×	496 1.1×	233 0.8×	346 1.7×	70 0.4×	54	1.3k
Piangkwan Sa‐nguanmoo Thailand	17	286 0.5×	324 0.7×	382 1.4×	127 0.6×	80 0.4×	31	926
Benjamin M. Terry United States	5	300 0.5×	839 1.8×	432 1.6×	128 0.6×	263 1.5×	8	1.4k
Antonietta Fava Italy	16	193 0.3×	381 0.8×	147 0.5×	77 0.4×	88 0.5×	26	988
Emma Bingham United Kingdom	7	207 0.4×	302 0.7×	158 0.6×	127 0.6×	122 0.7×	13	738
Silvia Maioli Sweden	16	117 0.2×	404 0.9×	354 1.3×	294 1.4×	134 0.7×	40	1.0k

Countries citing papers authored by Michael Gejl

Since Specialization

Citations

This map shows the geographic impact of Michael Gejl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gejl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gejl more than expected).

Fields of papers citing papers by Michael Gejl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gejl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gejl. The network helps show where Michael Gejl may publish in the future.

Co-authorship network of co-authors of Michael Gejl

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gejl. A scholar is included among the top collaborators of Michael Gejl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gejl. Michael Gejl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jensen, Nicole Jacqueline, Helena Zander Wodschow, Helene Speyer, et al.. (2024). Relation of Insulin Resistance to Brain Glucose Metabolism in Fasting and Hyperinsulinemic States: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 110(2). e525–e537. 4 indexed citations

Nilsson, Malin, Nicole Jacqueline Jensen, Michael Gejl, et al.. (2019). Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial. Diabetologia. 62(10). 1948–1958. 27 indexed citations

Svart, Mads, Lars Christian Gormsen, Jakob Hansen, et al.. (2018). Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial. PLoS ONE. 13(2). e0190556–e0190556. 74 indexed citations

Nilsson, Malin, Albert Gjedde, Birgitte Brock, Michael Gejl, & Jørgen Rungby. (2017). The effects of incretin hormones on cerebral glucose metabolism in health and disease. Neuropharmacology. 136(Pt B). 243–250. 8 indexed citations

Gejl, Michael, Birgitte Brock, Lærke Egefjord, et al.. (2017). Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment. Scientific Reports. 7(1). 17490–17490. 124 indexed citations

Gejl, Michael, Albert Gjedde, Birgitte Brock, et al.. (2017). Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial. Diabetologia. 61(3). 551–561. 15 indexed citations

Hansen, Allan K., Michael Gejl, Kirsten Bouchelouche, Lars Poulsen Tolbod, & Lars Christian Gormsen. (2016). Reverse Mismatch Pattern in Cardiac 18F-FDG Viability PET/CT Is Not Associated With Poor Outcome of Revascularization. Clinical Nuclear Medicine. 41(10). e428–e435. 6 indexed citations

Brock, Birgitte, et al.. (2016). Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain Trauma. Frontiers in Pharmacology. 7. 450–450. 22 indexed citations

Gejl, Michael, Albert Gjedde, Lærke Egefjord, et al.. (2016). In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial. Frontiers in Aging Neuroscience. 8. 108–108. 346 indexed citations breakdown →

10.

Brock, Birgitte, Michael Gejl, Anne M. Landau, et al.. (2016). Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats. Frontiers in Pharmacology. 7. 433–433. 28 indexed citations

11.

Starup‐Linde, Jakob, Michael Gejl, Per Borghammer, et al.. (2016). Vagotomy and subsequent development of diabetes – A nested case–control study. Metabolism. 65(7). 954–960. 7 indexed citations

12.

Gejl, Michael, et al.. (2014). Risk of cardiovascular disease events: The impact of diabetes and anti-diabetic drugs: A nested case-control study. Diabetologia. 57. 1 indexed citations

13.

Gejl, Michael, et al.. (2014). Risk of cardiovascular disease: The effects of diabetes and anti-diabetic drugs — A nested case–control study. International Journal of Cardiology. 178. 292–296. 26 indexed citations

14.

Hansen, Jan, Birgitte Brock, Hans Erik Bøtker, et al.. (2014). Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited. Reviews in Endocrine and Metabolic Disorders. 15(3). 219–231. 11 indexed citations

15.

Gejl, Michael, A. Mengel, Niels Møller, et al.. (2014). Influence of GLP-1 on Myocardial Glucose Metabolism in Healthy Men during Normo- or Hypoglycemia. PLoS ONE. 9(1). e83758–e83758. 22 indexed citations

16.

Gejl, Michael, Jørgen Rungby, Birgitte Brock, & Albert Gjedde. (2014). At the Centennial of Michaelis and Menten, Competing Michaelis–Menten Steps Explain Effect of GLP‐1 on Blood–Brain Transfer and Metabolism of Glucose. Basic & Clinical Pharmacology & Toxicology. 115(2). 162–171. 23 indexed citations

17.

Stender, Johan, Ron Kupers, Anders Rodell, et al.. (2014). Quantitative Rates of Brain Glucose Metabolism Distinguish Minimally Conscious from Vegetative State Patients. Journal of Cerebral Blood Flow & Metabolism. 35(1). 58–65. 86 indexed citations

18.

Gejl, Michael, Lærke Egefjord, Birgitte Brock, et al.. (2013). Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain. PubMed. 5. 2–2. 27 indexed citations

19.

Gejl, Michael, Hanne Maare Søndergaard, Bo Martin Bibby, et al.. (2012). Exenatide Alters Myocardial Glucose Transport and Uptake Depending on Insulin Resistance and Increases Myocardial Blood Flow in Patients with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 97(7). E1165–E1169. 66 indexed citations

20.

Bak, Ann Mosegaard, Lærke Egefjord, Michael Gejl, et al.. (2011). Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes. Expert Opinion on Therapeutic Targets. 15(10). 1153–1162. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact